about three kinds of quinolones to treat respiratory infections cost - comparison（对三种喹诺酮类治疗呼吸道感染,比较成本）.docVIP

About three kinds of quinolones to treat respiratory infections cost - Comparison Network to write papers: [Abstract] Objective To observe the three kinds of quinolones to treat respiratory infections effects of the economic effects of three drugs. Methods hospital 90 cases of respiratory tract infections were randomly divided into 3 groups, A group (n = 30 given intravenous ciprofloxacin therapy, B group (n = 30 given intravenous moxifloxacin treatment, C group (n = 30 given intravenous infusion of levofloxacin treatment, three kinds of quinolones for the cost of - effectiveness analysis results total effective rate in group A and group B, C group, the differences were not significant (Pgt; 0.05, B group the total effective rate was significantly higher than group C, the difference was significant (P lt;0.05 , A group, B group, C group, the incidence of adverse reactions was no significant difference (Pgt; 0.05,3 drug treatment for every unit needs a treatment cost were 32.31 yuan, 54.19 yuan, 20.02 yuan, C group lowest cost Conclusion levofloxacin in the treatment of respiratory tract infections with the exact efficacy of safety, cost advantages, can be of clinical use. [Keywords:] pharmacoeconomic cost - effectiveness analysis of drug therapy in the treatment of respiratory tract infections quinolones Pharmacoeconomics is a combination of pharmacological and interdisciplinary economics, the discipline from an economic point of view, drug development and use of research to make limited resources to maximize the effectiveness of drugs, “cost - effectiveness analysis” is the most common methods of analysis, which cost in monetary units, the effect with biological or clinical unit, cost - effectiveness analysis and cost effectiveness ratio to represent each get a results, the net cost to pay, in a series of similar compare the effect of drug treatment programs, if the final results are similar or the same, the choice of cost - effectiveness ratio is the sma